Top compounds associated with response to EIF2AK2


Feature Type Standardized
Nominal ANOVA
mRNA tubastatin A GDSC1000 pan-cancer AAC -0.069 0.02
mRNA lovastatin CTRPv2 pan-cancer AAC 0.083 0.03
mRNA Vinblastine GDSC1000 pan-cancer AAC -0.076 0.03
mRNA Rapamycin GDSC1000 pan-cancer AAC 0.11 0.03
mRNA THZ-2-49 GDSC1000 pan-cancer AAC -0.065 0.03
mRNA Vandetanib CCLE pan-cancer AAC 0.1 0.03
mRNA OSI-906 CTRPv2 pan-cancer AAC -0.077 0.03
mRNA GSK-650394 GDSC1000 pan-cancer AAC -0.077 0.03
mRNA YM201636 GDSC1000 pan-cancer AAC -0.067 0.03
mRNA RDEA119 GDSC1000 pan-cancer AAC 0.065 0.03
Download CSV